Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)

NCT01170052 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

20

Enrollment

OTHER

Sponsor class

Stopped insufficient enrollment

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Temsirolimus
DRUG: Bendamustine
DRUG: Temsirolimus

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]
[object Object]